PAPADOPOULOS STELIOS - Insider Non-Derivative Transactions at Regulus Therapeutics Inc. (RGLS) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Jun 25, 2025, PAPADOPOULOS STELIOS's relationship to Regulus Therapeutics Inc. (RGLS) is Director, and currently has 64,635 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other RGLS insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

PAPADOPOULOS STELIOS - Insider Non-Derivative Transactions of RGLS Common Stock

PAPADOPOULOS STELIOS - Insider Non-Derivative Transactions at RGLS

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Jun 26, 2025	Disposition -- (Common Stock)	64635	0	0
Jun 26, 2025	U -- (Common Stock)	976253	0	64635
May 1, 2025	Acquisition -- (Common Stock)	62500	0	1040888
Mar 15, 2024	Acquisition -- (Common Stock)	250000	1.6	978388
Apr 14, 2023	Acquisition -- (Common Stock)	222198	0.9	728388